![Robert Niecestro](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Niecestro
Direktor/Vorstandsmitglied bei
Aspargo Laboratories, Inc.
Profil
Robert Niecestro was the founder of TG Therapeutics, Inc. (2011, Executive Vice President-Clinical & Regulatory) and Axsome Therapeutics, Inc. (2012, Vice President-Clinical & Regulatory).
Current jobs include Managing Director at AccelaPHARM LLC and Independent Director at Aspargo Labs, Inc. Former jobs include Senior Director-Clinical Development at Eisai, Inc., Director-Clinical Operations at Organon USA, Inc., Vice President-Clinical & Regulatory Affairs at Keryx Biopharmaceuticals, Inc., Vice President-Clinical Development at Andrx Laboratories, Inc., and Head-Regulatory Affairs at Tharimmune, Inc. Education includes an undergraduate degree from the University of Illinois and a doctorate from The University of Chicago.
Aktive Positionen von Robert Niecestro
| Unternehmen | Position | Beginn |
|---|---|---|
AccelaPHARM LLC | Corporate Officer/Principal | - |
Aspargo Laboratories, Inc.
 Aspargo Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company focused on commercializing oral spray formulation of sildenafil citrate | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Robert Niecestro
| Unternehmen | Position | Ende |
|---|---|---|
| KERYX BIOPHARMACEUTICALS | Corporate Officer/Principal | - |
| CANTON STRATEGIC HOLDINGS, INC. | General Counsel | - |
Organon USA, Inc. | Corporate Officer/Principal | - |
Eisai, Inc.
 Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | Corporate Officer/Principal | - |
Andrx Laboratories, Inc.
 Andrx Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactured specialty pharmaceuticals | Corporate Officer/Principal | - |
Ausbildung von Robert Niecestro
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
11
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
TG Therapeutics, Inc.
 TG Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
Axsome Therapeutics, Inc.
 Axsome Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures novel therapies for the management of central nervous system | Health Technology |
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | Health Technology |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Illinois
 University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Organon USA, Inc. | |
Andrx Laboratories, Inc.
Andrx Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactured specialty pharmaceuticals | Health Technology |
Aspargo Laboratories, Inc.
Aspargo Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company focused on commercializing oral spray formulation of sildenafil citrate | Health Technology |
Tharimmune, Inc.
 Tharimmune, Inc. Data Processing ServicesTechnology Services Engages in institutional blockchain infrastructure and digital asset treasury management and clinical stage bio-technology services | Technology Services |
AccelaPHARM LLC |
